Abstract
We recently reported a convergent strategy to access the polycyclic guanidinium alkaloid (+)-batzelladine B via an aldol addition–retro-aldol–aza-Michael addition cascade. Here we describe the application of this approach toward the total syntheses of (+)-batzelladine E, (−)-dehydrobatzelladine C, and (+)-batzelladine K. The identification of suitable methods to functionalize a common tropane core by electrophilic alkynylation and nucleophilic 1,2-addition were essential to generalizing this approach. We provide evidence for the intermediacy of an acylallene species in the cascade reaction.
Keywords: Total synthesis, Alkaloid, Tropane, Batzelladine, Dehydrobatzelladine
1. Introduction
The batezlladines are a family of marine alkaloids that possess a tricyclic guanidinium core (Fig. 1).1–5 Two linear hydrocarbon side chains of varying length extend from this system. The guanidinium residue is embedded in an anti- or syn-2,5-disubstitued pyrrolidine ring, as exemplified by (+)-batzelladine A (1) and (+)-batzelladine B (3), respectively.1
Fig. 1.

Structures of (+)-batzelladine A (1), (−)-batzelladine D (2), (+)-batzelladine B (3), (+)-batzelladine E (4), (−)-dehydrobatzelladine C (5), and (+)-batzelladine K (6).
The challenges presented by this ring system have attracted considerable attention from synthetic chemists over the preceding decades.6–26 We recently disclosed the first total synthesis of the syn-pyrrolidine alkaloid (+)-batzelladine B (3) by a convergent approach.27 As shown in Scheme 1A, diastereoselective electrophilic alkynylation of the enoxysilane 7 using Waser’s reagent (TMS-EBX)28 provided the alkynylation product 8 (>80%). A key step then involved the conversion of the tropane intermediate 8 to the bicyclic guanidine 12 by an aldol addition–retro-aldol–aza-Michael addition cascade, using lithium benzyl octanoate (9) as nucleophile. Hydrogenolysis and decarboxylation then afforded the ketone 13 (48% from 8).
Scheme 1.

A. Synthesis of the bicyclic guanidine 13, a precursor to (+)-batzelladine B (3), via an aldol addition–retro-aldol–aza-Michael addition cascade. B. Outline of a general synthetic strategy toward syn-pyrrolidine guanidinium natural products.
As outlined in Scheme 1B, this convergent approach could conceivably enable access to additional targets by modulating the alkynylation and nucleophilic reagents. In particular we sought to investigate the suitability of unstabilized nucleophiles in the addition, as this would eliminate the extraneous decarboxylation required in the original synthesis (12→13, Scheme 1A). Here we describe the realization of this goal and the syntheses of (+)-batzelladine E (4),1 (−)-dehydrobatzelladine C (5),3 and (+)-batzelladine K (6).4
2. Results and discussion
Our synthetic route began with the N-amidinylpyrrole 14, which is accessible in two steps and 75% yield from 3-pyrroline (Scheme 2).27 In our original work, we prepared the dehydrotropane intermediate 7 by a double stereo-differentiating, formal [4 + 3] cycloaddition using a chiral α-diazoester and a chiral dirhodium catalyst. In the present work, we employed a chiral catalyst and the achiral α-diazoester 15 instead, as this combination provided acceptable levels of stereoselectivity. Moreover, the use of a bulky tert-butyl ester was necessary in the subsequent organo-metallic addition (vide infra). Because (+)-batzelladine E (4), (−)-dehydrobatzelladine C (5), and (+)-batzelladine K (6) are pseudoenantiomeric with respect to the positionally-equivalent sites within (+)-batzelladine B (3), the pseudoenantiomeric dehydrotropane 16 was prepared. In the event, heating 14 and 15 with dirhodium(II) tetrakis[N-phthaloyl-(R)-tert-leucinate] (Rh2[(R)pttl]4) as catalyst provided the dehydrotropane 16 in 88% yield and 88:12 er.27,29 The β-ketoester 17 was obtained by selective hydrogenation of the less-hindered olefin with chlorotris(triphenylphosphine)rhodium(I) as catalyst, followed by cleavage of the enoxysilane (tetra-n-butylammonium fluoride, TBAF). Treatment of the unpurified product 17 with lead(IV) acetate in the presence of trimethylstannyl(butyl)acetylene then furnished the α-alkynyl-β-ketoester 18 as a single diastereomer (1H NMR analysis; 80% from 16).30,31 The relative stereochemistry of 18 was assigned by analogy to 8. The use of trimethylstannyl(butyl)acetylene in the alkynylation allows for introduction of the requisite C-ring extension and a handle for construction of the C-ring in a single operation (see Fig. 1).
Scheme 2.

Synthesis of the α-alkynyl-β-ketoester 18.
The addition of unstabilized nucleophiles to the tropane 18 proved to be challenging. In our original synthesis using ester enolates as nucleophiles, the initial product formed following the retro-aldol possesses an acidic β-ketoester function, which can neutralize the ester enolate leaving group (see 10→11, Scheme 1). When unstabilized nucleophiles are employed, this acidic proton is not present, and products derived from elimination of the guanidine substituent were frequently observed. After extensive experimentation, we found that pre-complexation of the alkyne 18 with lanthanum(III) chloride bis(lithium chloride) complex32 (1 equiv) for 1 h at −40 °C, followed by treatment with an excess of an organomagnesium reagent at the same temperature resulted in clean and efficient conversion to the corresponding 1,2-addition products 19a–d (71–89%, Scheme 3). In each instance, a single diastereomer was formed, and the relative stereochemistry was established by 2D NOESY analysis. This analysis revealed the nucleophile added to the endo-face of the ketone. While isolation of 19a–d decreases the efficiency of the synthesis, this was mitigated by the generality of the addition, which allows for a high degree of modularity. The use of unstabilized nucleophiles in the addition eliminates the extraneous decarboxylation step in our earlier route (12→13, Scheme 1A).
Scheme 3.

Synthesis of the bicyclic guanidines 20a–c.
Having identified a robust and general method for incorporation of the A-ring carbon atoms, we next turned to effecting the remainder of the retro-aldol–aza-Michael cascade to access the desired bicyclic guanidines. Exposure of the addition products 19a–c to two equivalents of potassium bis(trimethylsilyl)amide (KHMDS) in tetrahydrofuran at −78 °C resulted in rapid opening of the tropane ring by a retro-aldol reaction. Low-temperature dilution of these reaction mixtures with tert-butanol permitted the isolation of allenes arising from γ-protonation of the resulting ester enolates (19d→21, Scheme 3B), in line with previous studies.33 This finding supports the acylallene postulated as an intermediate in the aldol addition–retro-aldol–aza-Michael used to access (+)-batzelladine B (3). Simply aging (2.5 d) the diluted reaction mixtures at 23 °C resulted in smooth conversion to the corresponding bicyclic guanidines 20a–c in 63–71% yield. These products were obtained exclusively as E exocyclic alkene isomers (2D NOESY analysis).
With the bicyclic intermediates 20a–c in hand, the syntheses of (+)-batzelladine E (4), (−)-dehydrobatzelladine C (5), and (+)-batzelladine K (6) were accomplished in 1–4 steps (Scheme 4). Treatment of the bicycle 20a with trifluoroacetic acid at 0 °C effected cleavage of the tert-butyl ester and two tert-butyoxycarbonyl (Boc) protecting groups (Scheme 4A). In situ cyclodehydration, decarboxylation of the liberated acid, and reduction of the two resulting enamine residues with triethylsilane then provided (+)-batzelladine K (6, 27%). Alternatively, global deprotection of the bicycle 20b with trifluoroacetic acid, followed by intra-molecular reductive amination, generated the tricyclic acid 23 (Scheme 4B). The carboxylic acid 23 was unstable toward purification and was used directly. Stepwise coupling34 with the alcohol 22 and cleavage of the newly introduced Boc protective groups with trifluoroacetic acid provided (+)-batzelladine E (4, 11% from 20b). Finally, reductive amination of 20c with palladium on carbon under dihydrogen in trifluoroacetic acid generated the tricyclic acid 24 (55%, Scheme 4C). The same protocol used to convert 23 to 4 was then employed to access 25 (45%). Oxidation of 25 with ceric ammonium nitrate provided (−)-dehydrobatzelladine C (5, 40%).15
Scheme 4.

Completion of the total syntheses of (+)-batzelladine K (6), (+)-batzelladine E (4), and (−)-dehydrobatzelladine C (5).
3. Conclusion
In summary, we have generalized our route to (+)-batzelladine B (3) to access (+)-batzelladine E (4), (−)-dehydrobatzelladine C (5), and (+)-batzelladine K (6). A lead(IV) acetate-mediated alkynylation of a β-ketoester and the addition of unstabilized nucleophiles to the tropane core enabled generalization of our synthetic strategy. The isolation of the stable acylallene 21 supports the involvement of these intermediates in our rearrangement cascade. We envision that further development should allow adaption of this strategy to more elaborate guanidinium alkaloids.
4. Experimental section
4.1. General experimental procedures
All reactions were performed in single-neck, flame-dried, round-bottomed flasks fitted with rubber septa under a positive pressure of argon, unless otherwise noted. Air- and moisture-sensitive liquids were transferred via syringe or stainless steel cannula, or were handled in a nitrogen-filled drybox (working oxygen level <10 ppm). Organic solutions were concentrated by rotary evaporation at 28–32 °C. Flash-column chromatography was performed as described by Still et al.,35 employing silica gel (60 Å, 40–63 μm particle size) purchased from Silicycle (Quebec, Canada). Analytical thin-layered chromatography (TLC) was performed using glass plates pre-coated with silica gel (0.25 mm, 60 Å pore size) impregnated with a fluorescent indicator (254 nm). TLC plates were visualized by exposure to ultraviolet light (UV) and/or submersion in aqueous para-anisaldehyde (PAA), followed by brief heating on a hot plate (120 °C, 10–15 s).
4.2. Materials
Commercial solvents and reagents were used as received with the following exceptions. Dichloromethane was purified according to the method of Pangborn et al.36 Tetrahydrofuran was distilled from sodium–ebenzophenone under an atmosphere of nitrogen immediately before use. The molarities of commercial organomagnesium halide solutions were determined using the method described by Love et al.37 Lanthanum(III) chloride and lithium chloride were dried under vacuum (~150 mTorr) for 16 h at 125 °C, with vigorous stirring, and stored in a nitrogen-filled drybox.32 Solid potassium bis(trimethylsilyl)amide was stored in a nitrogen-filled drybox. Trifluoroacetic acid was fractionally distilled and degassed by three freeze-pump-thaw cycles prior to each use. (Z)-1-Bromohept-3-ene,38 the N-amidinylpyrrole 14,27 tert-butyl 3-((tert-butyldimethylsilyl)oxy)-2-diazobut-3-enoate (15),39 trimethylstannyl(butyl)acetylene,31 and the guanyl alcohol 22,40 were prepared according to literature procedures.
4.3. Instrumentation
Proton nuclear magnetic resonance spectra (1H NMR) were recorded at 500 or 600 MHz at 23 °C, unless otherwise noted. Chemical shifts are expressed in parts per million (ppm, δ scale) downfield from tetramethylsilane and are referenced to residual protium in the NMR solvent (CHCl3, δ 7.26; CHD2OD, δ 3.31). Data are represented as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet and/or multiple resonances, b = broad, app = apparent), coupling constant in Hertz, integration, and assignment. Proton-decoupled carbon nuclear magnetic resonance spectra (13C NMR) were recorded at 125 MHz at 24 °C, unless otherwise noted. Chemical shifts are expressed in parts per million (ppm, δ scale) downfield from tetramethylsilane and are referenced to the carbon resonances of the solvent (CDCl3, δ 77.0; CD3OD, δ 49.0). Distortionless enhancement by polarization transfer spectra [DEPT (135)] were recorded at 125 MHz at 24 °C, unless otherwise noted. 13C NMR and DEPT (135) data are combined and represented as follows: chemical shift, carbon type [obtained from DEPT (135) experiments]. Attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectra were obtained using a Thermo Electron Corporation Nicolet 6700 FTIR spectrometer referenced to a polystyrene standard. Data are represented as follows: frequency of absorption (cm−1), intensity of absorption (s = strong, m = medium, w = weak, br = broad). Analytical ultra high-performance liquid chromatography/mass spectrometry (UPLC/MS) was performed on a Waters UPLC/MS instrument equipped with a reverse-phase C18 column (1.7 μm particle size, 2.1 × 50 mm), dual atmospheric pressure chemical ionization (API)/electrospray (ESI) mass spectrometry detector, and photodiode array detector. Samples were eluted with a linear gradient of 5% acetonitrile–water containing 0.1% formic acid→100% acetonitrile containing 0.1% formic acid over 0.75 min, followed by 100% acetonitrile containing 0.1% formic acid for 0.75 min, at a flow rate of 800 μL/min. High-resolution mass spectrometry (HRMS) were obtained on a Waters UPLC/HRMS instrument equipped with a dual API/ESI high-resolution mass spectrometry detector and photodiode array detector. Unless otherwise noted, samples were eluted over a reverse-phase C18 column (1.7 μm particle size, 2.1 × 50 mm) with a linear gradient of 5% acetonitrile–water containing 0.1% formic acid→95% acetonitrile–water containing 0.1% formic acid for 1 min, at a flow rate of 600 mL/min. Preparative high performance liquid chromatography (HPLC) was performed on a Waters Sunfire™ preparative reverse-phase C8 SymmetryPrep™ column (7.0 μm particle size, 19 × 300 mm). Samples were detected with a Waters Diode Array Detector (DAD) G1315B. Analytical chiral stationary phase supercritical fluid chromatography (SFC) was performed on a Waters Investigator SFC System instrument equipped with a RegisPack (TM) column (5.0 μm particle size, 4.6 × 250 mm) heated to 35 °C. Samples were detected with a UV/VIS detector.
Note: For positional assignments of synthetic intermediates, as well as the structure of S1, see the Supplementary Material.
4.4. Preparation of lanthanum(III) chloride bis(lithium chloride) complex
Solutions of lanthanum(III) chloride bis(lithium chloride) complex were prepared by a modification of a published procedure.32 A mixture of dried lanthanum(III) chloride (880 mg, 3.60 mmol, 1 equiv) and dried lithium chloride (300 mg, 7.10 mmol, 1.97 equiv) was dissolved in tetrahydrofuran (5.0 mL) at 24 °C. The resulting solution was stirred for 4 h at 23 °C before use. These solutions were freshly prepared immediately before each Grignard addition (18→19a–d).
4.5. Synthesis of the dehydrotropane 16
Tetrakis[N-phthaloyl-(R)-tert-leucinato]dirhodium(II) ethyl acetate adduct (690 mg, 485 μmol, 0.020 equiv) was added to a suspension of the N-amidinylpyrrole 14 (7.50 g, 24.3 mmol, 1 equiv) in hexanes (1.3 L) in a three-neck round-bottomed flask at 23 °C. The reaction vessel was fitted with a reflux condenser, an addition funnel, and a rubber septum. The reaction vessel was then placed in a heating mantle prewarmed to 68 °C. The resulting turbid green mixture was stirred vigorously for 2 h at 68 °C. A solution of tertbutyl-3-((tert-butyldimethylsilyl)oxy)-2-diazobut-3-enoate (15; 10.1 g, 33.9 mmol, 1.40 equiv) in hexanes (170 mL) was added dropwise via addition funnel over 2 h at 68 °C. The reaction mixture became progressively more homogeneous over the course of the addition. Upon completion of the addition, the product mixture was cooled to 23 °C over 30 min. The cooled product mixture was concentrated. The residue obtained was purified by flash-column chromatography (eluting with 15% ethyl acetate–pentane initially, grading to 35% ethyl acetate–pentane, one step) to provide the dehydrotropane 16 as a light yellow, crystalline solid (12.4 g, 88%). The enantiomeric ratio (er) was determined to be 88:12 by chiral stationary phase supercritical fluid chromatography. The absolute stereochemical configuration was assigned by analogy to the literature.27,29 Rf = 0.25 (15% ethyl acetate–pentane; UV, PAA). 1H NMR (600 MHz, CDCl3): δ 10.43 (bs, 1H, NH), 6.50 (dd, J = 6.0, 2.6 Hz, 1H, H2), 5.95 (dd, J = 6.0, 2.6 Hz, 1H, H3), 5.28 (bs, 1H, H1), 5.03 (bs, 1H, H4), 3.13 (app d, J = 17.5 Hz, 1H, H5), 1.84 (app d, J = 17.8 Hz, 1H, H5), 1.48 (s, 18H, H7,8), 1.47 (s, 9H, H6), 0.90 (s, 9H, H9), 0.18 (s, 3H, H10), 0.16 (s, 3H, H10). 13C NMR (125 MHz, CDCl3): δ 163.3 (C), 157.5 (C), 153.5 (C), 151.4 (C), 150.0 (C), 137.4 (CH), 127.3 (CH), 116.0 (C), 82.0 (C), 79.8 (2 × C), 59.07 (CH), 57.3 (CH), 33.0 (CH2), 28.3 (3 × CH3), 28.2 (3 × CH3), 25.8 (6 × CH3), 18.5 (C), −3.87 (CH3), −3.71 (CH3). IR (ATR-FTIR), cm−1: 2978 (w), 1749 (m), 1717 (m), 1612 (m). HRMS-CI (m/z): [M + H]+ calcd for C29H50N3O7Si, 580.3413; found, 580.3385.
4.6. Synthesis of the tropane S1
Chlorotris(triphenylphosphine)rhodium(I) (296 mg, 320 μmol, 0.015 equiv) was added to a solution of the dehydrotopane 16 (12.4 g, 21.4 mmol, 1 equiv) in 2-propanol (71 mL) at 23 °C. The resulting heterogeneous red suspension was then sealed in a stainless steel hydrogenation chamber. The chamber was flushed with dihydrogen (3 × 10 atm) and then charged to 30 atm dihydrogen. The reaction mixture was stirred under dihydrogen for 18 h at 23 °C. The product mixture was then removed from the chamber, the solution was collected, and then concentrated. In preparative scale experiments, the residue obtained was used directly in the following step. An analytically-pure sample of the tropane S1 could be obtained by flash-column chromatography (eluting with 20% ethyl acetate–hexanes). Rf = 0.25 (20% ethyl acetate–pentane; UV, PAA). 1H NMR (600 MHz, CDCl3): δ 10.36 (bs, 1H, NH), 4.75 (bd, 2H, H1,4), 3.16 (app d, J = 17.7 Hz, 1H, H5), 2.25–2.15 (m, 2H, H2,3), 2.03–1.95 (m, 1H, H2), 1.93 (app d, J = 17.5 Hz, 1H, H5), 1.67 (m, 1H, H3), 1.48 (s, 18H, H7,8), 1.45 (s, 9H, H6), 0.92 (s, 9H, H9), 0.19 (s, 3H, H10), 0.16 (s, 3H, H10). 13C NMR (125 MHz, CDCl3): δ 163.6 (C), 162.9 (C), 158.1 (C), 152.0, (C), 150.5 (C), 115.6 (C), 81.7 (C), 79.7 (2 C), 57.1 (CH), 52.6 (CH), 40.2 (CH2), 34.5 (CH2), 28.7 (CH2), 28.3 (3 × CH3), 28.2 (3 × CH3), 28.1 (3 × CH3), 25.8 (3 × CH3),18.6 (C), −3.7 (CH3), −4.1 (CH3). IR (ATR-FTIR), cm−1: 2980 (w), 1746 (m), 1716 (m), 1607 (m). HRMS-CI (m/z): [M + H]+ calcd for C29H52N3O7Si, 582.3569; found, 582.3524.
4.7. Synthesis of the β-ketoester 17
A solution of tetrabutylammonium fluoride in tetrahydrofuran (1.0 M, 44.8 mL, 44.8 mmol, 2.10 equiv) was added dropwise via syringe pump over 15 min to a solution of the unpurified tropane S1 obtained in the preceding step (nominally 21.4 mmol, 1 equiv) in tetrahydrofuran (210 mL) at −78 °C. The resulting brown mixture was stirred for 30 min at 78 °C. The cold product mixture was diluted with saturated aqueous ammonium chloride solution (300 mL). The diluted product mixture was warmed over 2 h to 23 °C, with stirring. The warmed product mixture was diluted with ethyl acetate (200 mL). The resulting biphasic mixture was transferred to a separatory funnel, and the layers that formed were separated. The aqueous layer was extracted with ethyl acetate (3 × 200 mL). The organic layers were combined and the combined organic layers were washed with saturated aqueous sodium chloride solution (2 × 350 mL). The washed organic layer was dried over sodium sulfate. The dried solution was filtered and the filtrate was concentrated. In preparative experiments, the residue obtained was used directly in the following step. An analytically pure sample of the β-ketoester 17 could be obtained by flash-column chromatography (eluting with 25% ethyl acetate–hexanes). The product was obtained as a single C9 diastereomer (1H NMR analysis, stereochemistry not assigned). Rf = 0.34 (25% ethyl acetate–pentane; UV, PAA). 1H NMR (500 MHz, CD3OD): δ 4.65 (bs, 1H, H1), 4.56 (bs, 1H, H4), 3.19 (m, 1H, H5), 2.35 (app t, J = 14.1 Hz, 1H, H5), 2.30–2.21 (m, 1H, H2), 2.17–2.07 (m, 2H, H3,9), 1.92 (m, 1H, H2), 1.76–1.68 (m, 1H, H3), 1.58 (s, 9H, H6), 1.48 (s, 9H, H8), 1.43 (s, 9H, H7). 13C NMR (125 MHz, CD3OD): δ 203.8 (C), 170.9 (C), 168.7 (C), 168.4 (C), 151.1 (C), 83.0 (C), 82.9 (C), 80.5 (C), 55.7 (CH), 53.9 (CH), 37.9 (CH), 35.4 (CH2), 29.7 (CH2), 28.6 (6 × CH3), 28.4 (CH2), 28.1 (3 × CH3). IR (ATR-FTIR), cm−1: 2933 (w), 1728 (m), 1724 (m), 1601 (m). HRMS-CI (m/z): [M + H]+ calcd for C23H38N3O7, 468.2704; found, 468.2673.
4.8. Synthesis of the alkyne 18
Trimethylstannyl(butyl)acetylene (6.79 g, 27.6 mmol, 1.29 equiv) was added dropwise via syringe to a solution of the unpurified β-ketoester 17 obtained in the previous step (nominally 21.4 mmol, 1 equiv) in dichloromethane (110 mL) at 0 °C. Immediately upon completion of the addition, lead(IV) acetate (13.2 g, 29.8 mmol, 1.39 equiv) was added in one portion. The cooling bath was removed and the reaction mixture was warmed over 2 h to 23 °C. The product mixture was diluted sequentially with 1.0 M aqueous hydrogen chloride solution (150 mL), water (50 mL), and ethyl acetate (100 mL). The resulting biphasic mixture was transferred to a separatory funnel and the layers that formed were separated. The aqueous layer was extracted with ethyl acetate (3 × 100 mL). The organic layers were combined and the combined organic layers were washed with saturated aqueous sodium chloride solution (200 mL). The washed organic layer was dried over sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The residue obtained was purified by flash-column chromatography (eluting with 10% ethyl acetate–pentane) to afford the alkyne 18 as a clear yellow liquid (9.35 g, 80% from 16). The alkyne 18 was obtained as a single stereoisomer. The configuration of the newly-formed stereocenter was assigned by analogy to related compounds.27 Rf = 0.21 (10% ethyl acetate–pentane; UV, PAA). 1H NMR (600 MHz, CDCl3): δ 10.22 (bs, 1H, NH), 4.84 (bs, 1H, H1), 4.59 (bs, 1H, H4), 3.59 (app bs, 1H, H5a), 2.33 (m, 1H, H5b), 2.22 (dd, J = 14.4, 2.2, 1H, H2a), 2.20–2.12 (m, 3H, H3a, H9), 2.06–1.95 (m, 1H, H2b), 1.68–1.58 (m, 1H, H3b), 1.57–1.42 (m, 27H, H6–8), 1.45–1.38 (m, 2H, H10), 1.38–1.30 (m, 2H, H11), 0.86 (t, J = 7.2 Hz, 3H, H12). 13C NMR (125 MHz, CDCl3): δ 199.6 (C), 165.7 (C), 152.8 (C), 82.9 (2 × C), 82.0 (C), 79.7 (C), 74.2 (C), 63.8 (C), 63.1 (CH), 56.0 (CH), 44.7 (CH2), 30.1 (CH2), 28.1 (3 × CH3), 27.9 (6 × CH3), 27.6 (CH2), 25.2 (CH2), 21.8 (CH2), 18.4 (CH2), 13.5 (CH3). Note: Two carbamate 13C shifts were not detected due to line broadening. IR (ATR-FTIR), cm−1: 3009 (w), 2933 (w), 1745 (m), 1725 (m). HRMS-CI (m/z): [M + H]+ calcd for C29H46N3O7, 548.3330; found, 548.3301.
4.9. Synthesis of the alcohol 19a
A solution of lanthanum(III) chloride bis(lithium chloride) complex in tetrahydrofuran (0.72 M, 7.94 mL, 5.72 mmol, 1.01 equiv) was added dropwise via syringe to a solution of the alkyne 18 (3.10 g, 5.67 mmol, 1 equiv) in tetrahydrofuran (110 mL) at −40 °C. The resulting turbid yellow mixture was stirred for 1 h at −40 °C. A solution of methyl magnesium bromide in ether (3.0 M, 6.60 mL, 19.8 mmol, 3.49 equiv) was added dropwise via syringe. The resulting mixture was stirred for 3 h at −40 °C. The cold dark yellow product mixture was diluted sequentially with saturated aqueous ammonium chloride solution (60 mL), water (60 mL), and ethyl acetate (100 mL). The resulting biphasic mixture was transferred to a separatory funnel and the layers that formed were separated. The aqueous layer was extracted with ethyl acetate (4 × 100 mL). The organic layers were combined and the combined organic layers were washed with saturated aqueous sodium chloride solution (50 mL). The washed organic layer was dried over sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The residue obtained was purified by flash-column chromatography (eluting with 15% ethyl acetate–hexanes) to afford the alcohol 19a as a viscous yellow oil (2.84 g, 89%). The alcohol 19a was obtained as a single stereoisomer (1H NMR analysis). The configuration of the newly-formed stereocenter was assigned by analogy to 19b (vide infra). Rf = 0.22 (15% ethyl acetate–hexanes; UV, PAA). 1H NMR (600 MHz, CDCl3): δ 10.27 (bs, 1H, NH), 4.60 (m, 2H, H1,4), 3.69 (app s, 1H, H5a), 2.29–2.12 (m, 4H, H2a,5b,9), 2.11–2.05 (m, 1H, H3a), 1.91–1.81 (m, 1H, H2b), 1.67 (app d, J = 15.3 Hz, 1H, H3b), 1.49–1.46 (m, 30H, H6e8,13), 1.43–1.38 (m, 4H, H10,11), 0.90 (t, J = 6.9 Hz, 3H, H12). 13C NMR (125 MHz, CDCl3): δ 170.1 (C), 163.1 (C), 151.6 (C), 150.5 (C), 87.3 (C), 82.8 (C), 81.1 (C), 79.0 (C), 77.9 (C), 74.0 (CH), 64.0 (C), 55.9 (CH), 54.5 (C), 40.9 (CH2), 30.2 (CH2), 30.0 (CH2), 28.3 (3 × CH3), 28.1 (3 × CH3), 28.0 (3 × CH3), 27.1 (CH2), 25.5 (CH2), 21.7 (CH3), 18.3 (CH2), 13.6 (CH3). IR (ATR-FTIR), cm−1: 3300 (br), 2971 (m), 1725 (m), 1626 (m). HRMS-CI (m/z): [M + H]+ calcd for C30H50N3O7, 564.3643; found, 564.3599.
4.10. Synthesis of the alcohol 19b
4.10.1. Preparation of (Z)-hept-3-en-1-yl magnesium bromide
Neat (Z)-1-bromohept-3-ene (303 mg, 1.71 mmol, 0.19 equiv) was added to dry magnesium turnings (218 mg, 8.97 mmol, 1.00 equiv) at 23 °C. The reaction vessel was placed in an oil bath that had been preheated to 50 C. The mixture was stirred for 3 min at 50 °C. The reaction vessel was then removed from the oil bath. A solution of (Z)-1-bromohept-3-ene (1.21 g, 6.84 mmol, 0.76 equiv) in tetrahydrofuran (8.6 mL) was added via syringe. The reaction mixture was returned to the oil bath at 50 °C. The reaction mixture was stirred for 45 min at 50 °C. The product mixture was cooled over 30 min to 23 °C. The cooled solution of (Z)-hept-3-en-1-yl magnesium bromide obtained in this way (nominally 1.04 M) was used immediately in the following step.
4.10.2. Synthesis of the alcohol 19b
A solution of lanthanum(III) chloride bis(lithium chloride) complex in tetrahydrofuran (0.72 M, 2.56 mL, 1.84 mmol, 1.01 equiv) was added dropwise via syringe to a solution of the alkyne 18 (1.00 g,1.83 mmol,1 equiv) in tetrahydrofuran (31 mL) at −40 °C. The resulting turbid yellow mixture was stirred for 1 h at −40 °C. A solution of (Z)-hept-3-en-1-yl magnesium bromide in tetrahydrofuran (nominally 1.04 M, 6.40 mL, 6.66 mmol, 3.64 equiv) was then added dropwise via syringe at −40 °C. The reaction mixture was stirred for 3 h at −40 °C. The dark yellow product mixture was diluted sequentially with saturated aqueous ammonium chloride solution (30 mL), water (30 mL), and ethyl acetate (50 mL). The resulting biphasic mixture was transferred to a separatory funnel and the layers that formed were separated. The aqueous layer was extracted with ethyl acetate (4 × 60 mL). The organic layers were combined and the combined organic layers were washed with saturated aqueous sodium chloride solution (30 mL). The washed organic layers were dried over sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The residue obtained was purified by flash-column chromatography (eluting with 10% ethyl acetate–hexanes) to afford the alcohol 19b as a viscous yellow oil (943 mg, 80%). The alcohol 19b was obtained as a single stereoisomer (1H NMR analysis). The relative stereochemical configuration was determined by 2D-NOESY analysis (NOE from H13 to H3 observed). Rf = 0.18 (10% ethyl acetate–hexanes; UV, PAA). 1H NMR (500 MHz, CDCl3): δ 10.32 (bs, 1H, NH), 5.39–5.30 (m, 2H, H15,16), 4.67–4.55 (m, 2H, H1,4), 3.97 (app s, 1H, H5a), 2.25–2.21 (m, 6H, H2a,5b,9,17), 2.05–1.95 (m, 2H, H14), 1.94–1.85 (m, 2H, H2b,3a), 1.79 (app d, J = 14.1,1H, H3b),1.50 (s, 9H, H6),1.47 (s,18H, H7,8),1.45–1.31 (m, 8H, H10,11,13,18), 0.90 (app t, 6H, H12,19). 13C NMR (125 MHz, CDCl3): δ 170.7 (C), 163.1 (C), 151.6 (C), 150.5 (C), 129.9 (CH), 129.8 (CH), 87.8 (C), 82.9 (C), 81.1 (C), 79.1 (C), 77.2 (C), 75.6 (CH), 64.6 (C), 56.0 (CH), 54.4 (C), 41.5 (CH2), 38.3 (CH2), 30.2 (CH2), 29.3 (CH2), 28.3 (3 × CH3), 28.1 (3 × CH3), 27.1 (3 × CH3), 27.2 (CH2), 25.3 (CH2), 22.8 (CH2), 21.7 (CH2), 20.6 (CH2), 18.4 (CH2), 13.8 (CH3), 13.6 (CH3). IR (ATR-FTIR), cm−1: 3349 (br), 3009 (w), 2973 (w), 1729 (m), 1603 (m). HRMS-CI (m/z): [M + H]+ calcd for C36H60N3O7, 646.4426; found, 646.4376.
4.11. Synthesis of the alcohol 19c
A solution of lanthanum(III) chloride bis(lithium chloride) complex in tetrahydrofuran (0.72 M, 2.56 mL, 1.84 mmol, 1.00 equiv) was added dropwise via syringe to a solution of the alkyne 18 (1.00 g,1.83 mmol,1 equiv) in tetrahydrofuran (31 mL) at −40 °C. The resulting turbid yellow mixture was stirred for 1 h at −40 °C. A solution of n-heptylmagnesium bromide in ether (1.0 M, 6.40 mL, 6.40 mmol, 3.50 equiv) was added dropwise via syringe. The reaction mixture was stirred for 3 h at −40 °C. The cold, dark yellow product mixture was diluted sequentially with saturated aqueous ammonium chloride solution (30 mL), water (30 mL), and ethyl acetate (50 mL). The resulting biphasic mixture was transferred to a separatory funnel and the layers that formed were separated. The aqueous layer was extracted with ethyl acetate (4 × 60 mL). The organic layers were combined and the combined organic layers were washed with saturated aqueous sodium chloride solution (30 mL). The washed organic layer was dried over sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The residue obtained was purified by flash-column chromatography (eluting with 10% ethyl acetate–hexanes) to afford the alcohol 19c as a viscous yellow oil (948 mg, 80%). The alcohol 19c was obtained as a single diastereomer (1H NMR analysis). The configuration of the newly-formed stereocenter was assigned by analogy to 19b (vide supra). Rf = 0.18 (10% ethyl acetate–hexanes; UV, PAA). 1H NMR (600 MHz, CDCl3): δ 10.32 (bs, 1H, NH), 4.60 (app br s, 2H, H1,4), 3.84 (app s, 1H, H5a), 2.25–2.15 (m, 2H, H2a,5b), 2.15–2.07 (m, 2H, H9), 1.92–1.83 (m, 2H, H2b,3a), 1.77 (app d, J = 14.2, 1H, H3b), 1.66–1.56 (m, 4H, H10,13), 1.50 (s, 9H, H7), 1.48 (s, 9H, H8), 1.47 (s, 9H, H6), 1.46–1.37 (m, 4H, H14,15), 1.31–1.2 (m, 8H, H11,16e18), 0.91 (t, J = 6.9 Hz, 3H, H12), 0.87 (t, J = 6.5 Hz, 3H, H19). 13C NMR (125 MHz, CDCl3): δ 170.7 (C), 163.1 (C), 151.6 (C), 150.5 (C), 87.7 (C), 82.9 (C), 81.1 (C), 79.1 (C), 77.5 (C), 75.7 (CH), 64.6 (C), 56.1 (CH), 54.5 (C), 41.6 (CH2), 38.4 (CH2), 31.8 (CH2), 30.3 (CH2), 30.1 (CH2), 29.4 (CH2), 28.3 (3 × CH3), 28.1 (3 × CH3), 27.8 (3 × CH3), 27.2 (CH2), 25.3 (CH2), 22.7 (CH2), 22.5 (CH2), 21.7 (CH2), 18.4 (CH2), 14.1 (CH3), 13.6 (CH3). IR (ATR-FTIR), cm−1: 3374 (br, w), 2948 (w), 1725 (m), 1610 (m). HRMS-CI (m/z): [M + H]+ calcd for C36H62N3O7, 648.4582; found, 648.4536.
4.12. Synthesis of the alcohol 19d
A solution of lanthanum(III) chloride bis(lithium chloride) complex in tetrahydrofuran (0.72 M, 11.2 mL, 8.06 mmol, 0.98 equiv) was added dropwise via syringe to a solution of the alkyne 18 (4.50 g, 8.22 mmol, 1 equiv) in tetrahydrofuran (110 mL) at −40 °C. The resulting turbid yellow mixture was stirred for 1 h at −40°C. A solution of n-butylmagnesium bromide in tetrahydrofuran (2.0 M, 14.0 mL, 28.0 mmol, 3.41 equiv) was added dropwise via syringe at −40 °C. The reaction mixture was stirred for 3 h at −40 °C. The cold, dark yellow product mixture was diluted sequentially with saturated aqueous ammonium chloride solution (100 mL), water (100 mL), and ethyl acetate (150 mL). The resulting biphasic mixture was transferred to a separatory funnel and the layers that formed were separated. The aqueous layer was extracted with ethyl acetate (4 × 100 mL). The organic layers were combined and the combined organic layers were washed with saturated aqueous sodium chloride solution (200 mL). The washed organic layer was dried over sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The residue obtained was purified by flash-column chromatography (eluting with 10% ethyl acetate–hexanes) to afford the alcohol 19d as a viscous yellow oil (3.52 g, 71%). The alcohol 19d was obtained as a single diastereomer (1H NMR analysis). The configuration of the newly-formed stereocenter was assigned by analogy to 19b (vide supra). Rf = 0.23 (10% ethyl acetate–hexanes; UV, PAA). 1H NMR (600 MHz, CDCl3): δ 10.31 (bs, 1H, NH), 4.64–4.57 (m, 2H, H1,4), 3.82 (s, 1H, H5a), 2.24–2.15 (m, 3H, H2a,9), 2.15–2.06 (m, 3H, H2b,3a,5b), 1.90–1.83 (m, 2H, H10),1.77 (d, J = 14.3,1H, H3b),1.49 (s, 9H, H7),1.46 (s,18H, H6,8), 1.44–1.36 (m, 4H, H13,14), 1.31–1.23 (m, 4H, H11,15), 0.93–0.85 (m, 6H, H12,16). 13C NMR (125 MHz, CDCl3): δ 170.7 (C), 163.1 (C), 151.6 (C), 150.5 (C), 87.7 (C), 82.9 (C), 81.1 (C), 79.1 (C), 77.5 (C), 75.7 (CH), 64.6 (C), 56.2 (CH), 54.4 (C), 41.3 (CH2), 38.4 (CH2), 30.3 (CH2), 28.3 (3 × CH3), 28.1 (3 × CH3), 27.8 (3 × CH3), 27.2 (CH2), 25.3 (CH2), 24.7 (CH2), 23.2 (CH2), 21.7 (CH2), 18.4 (CH2), 14.2 (CH3), 13.6 (CH3). IR (ATR-FTIR), cm−1: 3352 (br, w), 2970 (w), 1727 (m), 1605 (m). HRMS-CI (m/z): [M + H]+ calcd for C33H56N3O7, 606.4113; found, 606.4049.
4.13. Synthesis of the ketone 20a
A solution of potassium bis(trimethylsilyl)amide in tetrahydrofuran (1.0 M, 4.00 mL, 4.00 mmol, 2.15 equiv) was added dropwise via syringe to a solution of the alcohol 19a (1.05 g, 1.86 mmol, 1 equiv) in tetrahydrofuran (38 mL) at −78 °C. The resulting turbid yellow mixture was stirred for 2.5 h at −78 °C. The cold mixture was then diluted with a mixture of tert-butanol and ether (1:1 v/v, 2.5 mL) at −78 °C. The reaction mixture was warmed over 20 min to 23 °C, and the warmed mixture was stirred for 2.5 d at 23 °C. The light yellow product mixture was diluted sequentially with saturated aqueous ammonium chloride solution (30 mL) and ethyl acetate (50 mL). The resulting biphasic mixture was transferred to a separatory funnel and the layers that formed were separated. The aqueous layer was extracted with ethyl acetate (4 × 50 mL). The organic layers were combined and the combined organic layers were washed with saturated aqueous sodium chloride solution (200 mL). The washed organic layer was dried over sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The residue obtained was purified by flash-column chromatography (eluting with 30% ethyl acetate–hexanes) to afford the ketone 20a as a viscous yellow oil (661 mg, 63%). The ketone 20a was obtained as a single alkene and C15 stereoisomer (1H NMR analysis). The configuration of C15 was assigned by analogy to related compounds.27 The configuration of the alkene was obtained assigned by 2D-NOESY spectroscopy (NOE from H14 to H7 observed). Rf = 0.27 (35% ethyl acetate–hexanes; UV, PAA). 1H NMR (600 MHz, CDCl3): δ 5.83 (t, J = 7.8 Hz, 1H, H14), 4.46 (t, J = 7.9 Hz, 1H, H4), 3.87 (td, J = 9.5, 6.3 Hz, 1H, H1), 3.46 (d, J = 9.3 Hz, 1H, H15), 2.99 (dd, J = 16.7, 3.3 Hz, 1H, H5a), 2.40 (dd, J = 16.6, 9.8, 1H, H5b), 2.17–2.12 (m, 4H, H2a,3a,9), 2.10 (s, 3H, H13),1.84 (dd, J = 12.8, 6.9 Hz, 1H, H3b),1.74–1.65 (m,1H, H2b),1.48 (s, 9H, H6),1.45 (s, 9H, H8),1.45 (s, 9H, H7), 1.40–1.31 (m, 4H, H10,11), 0.89 (t, J = 6.9 Hz, 3H, H12). 13C NMR (125 MHz, CDCl3): δ 206.6 (C), 168.8 (C), 159.7 (C), 150.6 (C), 150.2 (C), 132.2 (CH), 127.8 (C), 81.9 (C), 81.8 (C), 78.9 (C), 59.0 (CH), 55.7 (CH), 53.2 (CH), 46.3 (CH2), 30.8 (CH2), 30.5 (CH2), 29.6 (CH2), 29.4 (CH2), 28.2 (3 × CH3), 28.0 (3 × CH3), 28.0 (3 × CH3), 27.7 (CH2), 22.5 (CH2), 13.9 (CH3). IR (ATR-FTIR), cm−1: 2979 (w), 2932 (w), 1736 (m), 1679 (m). HRMS-CI (m/z): [M + H]+ calcd for C30H50N3O7, 564.3643; found, 564.3609.
4.14. Synthesis of the ketone 20b
A solution of potassium bis(trimethylsilyl)amide in tetrahydrofuran (1.0 M, 3.18 mL, 3.18 mmol, 2.20 equiv) was added dropwise via syringe to a solution of the alcohol 19b (930 mg, 1.44 mmol, 1 equiv) in tetrahydrofuran (29 mL) at −78 °C. The resulting turbid yellow mixture was stirred for 2.5 h at −78 °C. The solution was then diluted with a mixture of tert-butanol and ether (1:1 v/v, 2.5 mL) at −78 °C. The diluted mixture was warmed over 20 min to 23 °C, and the warmed solution was stirred for 2.5 d at 23 °C. The light yellow product mixture was diluted sequentially with saturated aqueous ammonium chloride solution (30 mL) and ethyl acetate (50 mL). The resulting biphasic mixture was transferred to a separatory funnel and the layers that formed were separated. The aqueous layer was extracted with ethyl acetate (4 × 60 mL). The organic layers were combined and the combined organic layers were washed with saturated aqueous sodium chloride solution (30 mL). The washed organic layer was dried over sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The residue obtained was purified by flash-column chromatography (eluting with 30% ethyl acetate–hexanes) to afford the ketone 20b as a viscous yellow oil (660 mg, 71%). The ketone 20b was obtained as a single alkene and C21 stereoisomer (1H NMR analysis). The configuration of C21 was assigned by analogy to related compounds.27 The configuration of the alkene was obtained assigned by 2D-NOESY spectroscopy (NOE from H20 to H7 observed). Rf = 0.26 (30% ethyl acetate–hexanes; UV, PAA). 1H NMR (600 MHz, CDCl3): δ 5.84 (t, J = 7.8 Hz, 1H, H20), 5.39–5.35 (m, 1H, H15), 5.35–5.26 (m, 1H, H16), 4.47 (t, J = 9.0 Hz, 1H, H4), 3.87 (td, J = 9.4, 6.0 Hz,1H, H1), 3.46 (d, J = 9.4 Hz,1H, H21), 3.01 (dd, J = 16.5, 3.3 Hz, 1H, H5a), 2.45–2.37 (m, 2H, H13), 2.36 (app d, 9.3 Hz, 1H, H5b), 2.30–2.22 (m, 2H, H17), 2.19–2.07 (m, 3H, H2a,9), 2.05–1.96 (m, 2H, H14),1.85 (dd, J = 12.7, 6.7 Hz,1H, H3a), 1.76–1.58 (m, 2H, H2b,3b), 1.49 (s, 9H, H6), 1.45 (s, 9H, H8), 1.44 (s, 9H, H7), 1.41–1.32 (m, 6H, H10,11,18), 0.93–0.83 (m, 6H, H12,19). 13C NMR (125 MHz, CDCl3): δ 208.5 (C), 168.8 (C), 159.8 (C),150.6 (C), 150.2 (C), 132.2 (CH),131.0 (CH), 127.8 (2 × CH), 81.9 (C), 81.8 (C), 78.9 (C), 58.8 (CH), 55.7 (CH), 53.3 (CH), 45.5 (CH2), 43.1 (CH2), 30.9 (CH2), 29.6 (CH2), 29.4 (CH2), 29.2 (CH2), 28.3 (3 × CH3), 28.0 (6 × CH3), 27.8 (CH2), 22.7 (CH2), 22.6 (CH2), 21.5 (CH2), 13.9 (CH3), 13.7 (CH3). IR (ATR-FTIR), cm−1: 2957 (w), 1727 (m), 1720 (m), 1604 (m). HRMS-CI (m/z): [M + H]+ calcd for C36H60N3O7, 646.4426; found, 646.4383.
4.15. Synthesis of the ketone 20c
A solution of potassium bis(trimethylsilyl)amide in tetrahydrofuran (1.0 M, 3.24 mL, 3.24 mmol, 2.10 equiv) was added dropwise via syringe to a solution of the alcohol 19c (1.00 g, 1.54 mmol, 1 equiv) in tetrahydrofuran (31 mL) at −78 °C. The resulting turbid yellow mixture was stirred for 2.5 h at −78 °C. The solution was then diluted with a mixture of tert-butanol and ether (1:1 v/v, 2.5 mL) at −78 °C. The diluted mixture was warmed over 20 min to 23 °C, and the warmed solution was stirred for 2.5 d at 23 °C. The light yellow product mixture was diluted sequentially with saturated aqueous ammonium chloride solution (30 mL) and ethyl acetate (50 mL). The resulting biphasic mixture was transferred to a separatory funnel and the layers that formed were separated. The aqueous layer was extracted with ethyl acetate (4 × 60 mL). The organic layers were combined and the combined organic layers were washed with saturated aqueous sodium chloride solution (30 mL). The washed organic layer was dried over sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The residue obtained was purified by flash-column chromatography (eluting with 30% ethyl acetate–hexanes) to afford the ketone 20c as a viscous yellow oil (680 mg, 68%). The ketone 20c was obtained as a single alkene and C21 stereoisomer (1H NMR analysis). The configuration of C21 was assigned by analogy to related compounds.27 The configuration of the alkene was obtained assigned by 2D-NOESY spectroscopy (NOE from H20 to H7 observed). Rf = 0.24 (30% ethyl acetate–hexanes; UV, PAA). 1H NMR (600 MHz, CDCl3): δ 5.83 (t, J = 7.8 Hz, 1H, H20), 4.46 (t, J = 8.3 Hz, 1H, H4), 3.87 (td, J = 9.5, 6.1 Hz, 1H, H1), 3.46 (d, J = 9.4 Hz, 1H, H21), 2.99 (dd, J = 16.4, 3.2 Hz, 1H, H5a), 2.42–2.30 (m, 3H, H5b,13), 2.20–2.00 (m, 4H, H 2a,3a,9), 1.85 (dd, J = 12.8, 6.9 Hz, 1H, H3b), 1.77–1.65 (m, 1H, H2b), 1.55–1.46 (m, 11H, H14, H6), 1.45 (s, 9H, H8), 1.43 (s, 9H, H7), 1.44–1.30 (m, 4H, H10,11), 1.30–1.15 (m, 8H, H15–18), 0.92–0.83 (m, 6H, H12,19). 13C NMR (125 MHz, CDCl3): δ 209.2 (C), 168.8 (C), 159.7 (C), 150.6 (C), 150.2 (C), 132.2 (CH), 127.8 (C), 81.9 (C), 81.8 (C), 78.8 (C), 59.0 (CH), 55.7 (CH), 53.4 (CH), 45.3 (CH2), 43.4 (CH2), 31.7 (CH2), 30.9 (CH2), 29.6 (CH2), 29.4 (CH2), 29.2 (CH2), 29.0 (CH2), 28.3 (3 × CH3), 28.0 (6 × CH3), 27.8 (CH2), 23.7 (CH2), 22.6 (CH2), 22.6 (CH2), 14.0 (CH3), 13.9 (CH3). IR (ATR-FTIR), cm−1: 2959 (w), 2931 (w), 1719 (m), 1609 (m). HRMS-CI (m/z): [M + H]+ calcd for C36H62N3O7, 648.4582; found, 648.4551.
4.16. Synthesis of the allene 21
A solution of potassium bis(trimethylsilyl)amide in tetrahydrofuran (1.0 M, 4.03 mL, 4.03 mmol, 2.11 equiv) was added dropwise via syringe to a solution of the alcohol 19d (1.16 g, 1.91 mmol, 1 equiv) in tetrahydrofuran (38 mL) at −78 °C. The resulting turbid yellow mixture was stirred for 2.5 h at −78 °C. The solution was diluted with a mixture of tert-butanol and ether (1:1 v/v, 5.0 mL) at −78 °C. The diluted product mixture was stirred for 10 min at −78 °C. The mixture was then diluted sequentially with saturated aqueous ammonium chloride solution (30 mL) and ethyl acetate (30 mL). The resulting biphasic mixture was transferred to a separatory funnel and the layers that formed were separated. The aqueous layer was extracted with ethyl acetate (4 × 50 mL). The organic layers were combined and the combined organic layers were washed with saturated aqueous sodium chloride solution (100 mL). The washed organic layer was dried over sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The residue obtained was purified by flash-column chromatography (eluting with 20% ethyl acetate–hexanes) to afford the allene 21 as a colorless oil (1.03 g, 89%). Rf = 0.19 (20% ethyl acetate–hexanes; UV, PAA). 1H NMR (600 MHz, CDCl3): δ 5.69 (t, J = 7.4 Hz, 1H, H20), 4.87 (bs, 1H, H1), 4.52 (bs, 1H, H4), 3.27 (dd, J = 16.2, 3.7 Hz, 1H, H5a), 2.45–2.35 (m, 2H, H13), 2.25–2.15 (m, 2H, H2a,5b), 2.15–2.07 (m, 2H, H9), 1.85 (dd, J = 12.1, 5.8 Hz, 1H, H3a), 1.70–1.63 (m, 1H, H2b), 1.63–1.56 (m, 1H, H3b), 1.56–1.50 (m, 2H, H10), 1.46 (s, 27H, H6–8), 1.44–1.35 (m, 4H, H14,15), 1.35–1.24 (m, 2H, H11), 0.94–0.86 (m, 6H, H12,16). 13C NMR (125 MHz, CDCl3): δ 209.6 (C), 208.3 (C), 165.9 (C), 161.1 (C), 145.9 (C), 130.6 (C), 104.6 (CH), 98.0 (C), 96.9 (C), 81.6 (C), 81.5 (C), 58.1 (CH), 56.3 (CH), 49.8 (CH2), 47.3 (CH2), 42.9 (CH2), 39.8 (CH2), 33.1 (CH2), 31.1 (CH2), 28.4 (3 × CH3), 28.1 (6 × CH3), 27.9 (CH2), 26.0 (CH2), 22.3 (CH2), 22.0 (CH2), 13.8 (CH3), 13.8 (CH3). IR (ATR-FTIR), cm−1: 2950 (w), 1728 (m), 1701 (m), 1606 (s). HRMS-CI (m/z): [M + H]+ calcd for C33H56N3O7, 606.4113; found, 606.4061.
4.17. Synthesis of (+)-batzelladine K (6)
Chilled (−15 °C), freshly-distilled, and degassed trifluoroacetic acid (8.3 mL) was added to a round-bottomed flask containing the neat ketone 20a (235 mg, 417 μmol, 1 equiv) precooled to 0 °C. The reaction mixture was stirred for 3 h at 0 °C. Triethylsilane (134 μL, 839 μmol, 2.01 equiv) was then added. The resulting mixture was stirred for 1 h at 0 °C. The cold product mixture was diluted with methanol (2.0 mL). The diluted product mixture was filtered through a pad of celite (0.8 × 4 cm). The filter cake was washed with methanol (3 × 3.0 mL). The filtrates were combined and the combined filtrates were concentrated. The residue obtained was purified by preparative high-performance liquid chromatography (eluting with 0.1% formic acid–5% acetonitrile–water initially, grading to 0.1% formic acid–49% acetonitrile–water over 15 min,10 injections) to furnish (+)-batzelladine K (6) as a colorless oil (33.0 mg, 27%). Rf = 0.21 (10% methanol–dichloromethane; UV, PAA). 1H NMR (600 MHz, CDCl3): δ 9.61 (bs, 1H, NH), 9.36 (bs, 1H, NH), 3.69–3.60 (m, 2H, H4,7), 3.55–3.47 (m, 1H, H2), 3.40–3.32 (m, 1H, H9), 2.25–2.17 (m, 3H, H3a,6a,8a), 2.18–2.11 (m, 1H, H5a), 1.75–1.67 (m, 2H, H5b,6b), 1.65–1.60 (m, 1H, H11a), 1.53–1.45 (m, 1H, H11b), 1.39–1.26 (m, 6H, H12–14), 1.33 (d, J = 5.8 Hz, 3H, H1), 1.27–1.17 (m, 2H, H3b,8b), 0.89 (t, J = 6.9 Hz, 3H, H15). 13C NMR (125 MHz, CDCl3): δ 150.0 (C), 56.0 (CH), 55.8 (CH), 50.2 (CH), 45.8 (CH), 36.2 (CH2), 34.4 (CH2), 33.9 (CH2), 31.5 (CH2), 30.4 (CH2), 30.4 (CH2), 24.9 (CH2), 22.5 (CH2), 20.3 (CH3), 13.9 (CH3). IR (ATR-FTIR), cm−1: 3358 (br), 2974 (w), 1688 (w), 1629 (w). HRMS-CI (m/z): [M]+ calcd for C15H28N3, 250.2278; found, 250.2284.
4.18. Synthesis of (+)-batzelladine E (4)
4.18.1. Synthesis of the carboxylic acid 23
Chilled (−15 °C), freshly-distilled, and degassed trifluoroacetic acid (5.7 mL) was added to a round-bottomed flask containing the neat ketone 20b (185 mg, 286 μmol, 1 equiv) precooled to 0 °C. The reaction mixture was stirred for 3 h at 0 °C. The cold product mixture was diluted with methanol (2.0 mL). The diluted product mixture was filtered through a pad of celite (0.8 × 4.0 cm). The filter cake was washed with methanol (3 × 3.0 mL). The filtrates were combined and the combined filtrates were concentrated. The residue obtained was dissolved in methanol (4.8 mL) and the resulting solution was cooled to 0 °C. Sodium cyanoborohydride (19.0 mg, 302 μmol, 1.06 equiv) was then added to the solution in one portion. The reaction mixture was stirred for 2 h at 0 °C. The reaction mixture was allowed to warm over 1 h to 23 °C and was stirred for 17 h at 23 C. The light yellow product mixture was cooled to 0 °C and the cooled solution was diluted sequentially with 1 M aqueous hydrochloric acid solution (5.0 mL) and ethyl acetate (5.0 mL). The resulting biphasic mixture was transferred to a separatory funnel and the layers that formed were separated. The aqueous layer was extracted with ethyl acetate (4 × 5.0 mL). The organic layers were combined and the combined organic layers were dried over sodium sulfate. The dried solution was filtered and the filtrate was concentrated. Attempted isolation of 23 resulted in complex mixtures of unidentifiable decomposition products. Consequently, the residue obtained was used directly in the following step.
4.18.2. Synthesis of (+)-batzelladine E (4)
N-Methyl-2-chloropyridinium iodide (88.9 mg, 348 μmol, 1.22 equiv) was added in one portion to a solution of the carboxylic acid 23 (nominally 286 μmol, 1 equiv) in acetonitrile (960 μL) at 23 °C. The reaction was stirred for 1 h at 23 °C. The alcohol 22 (95.7 mg, 289 μmol, 1.01 equiv) and 4-dimethylaminopyridine (26.6 mg, 218 μmol, 0.74 equiv) were then added in sequence. The reaction vessel was then placed in an oil bath that had been preheated to 40 °C. The reaction mixture was stirred for 2 h at 40 °C. The product mixture was then cooled over 30 min to 23 °C. The cooled product mixture was filtered through a pad of celite (0.8 × 4.0 cm). The filter cake was washed with ethyl acetate (3 × 5.0 mL). The filtrates were combined and the combined filtrates were concentrated. The residue obtained was then cooled (neat) to 0 °C. Chilled (−15 °C), freshly distilled, degassed trifluoroacetic acid (5.7 mL) was then added. The reaction mixture was stirred for 3 h at 0 °C. The cold product mixture was diluted with methanol (2.0 mL). The diluted product mixture was filtered through a pad of celite (0.8 × 4.0 cm). The filter cake was rinsed with methanol (3 × 3.0 mL). The filtrates were combined and the combined filtrates were concentrated. The residue obtained was purified by flash-column chromatography (eluting with 10% methanol–dichloromethane). The fractions containing product were combined and the combined fractions were concentrated. The residue obtained was further purified by preparative thin-layer chromatography (eluting with 5% methanol–dichloromethane) to furnish (+)-batzelladine E (4) as a colorless solid (15.3 mg, 11% from 20b). Rf = 0.21 (10% methanol–dichloromethane; UV, PAA). 1H NMR (600 MHz, CD3OD): δ 5.47–5.35 (m, 2H, H23,24), 4.50 (dd, J = 6.8, 4.1, 1H, H8), 4.21 (t, J = 6.1, 2H, H5), 3.82–3.76 (m, 1H, H11), 3.55–3.51 (m, 1H, H13), 3.21 (t, J = 7.0, 2H, H2), 2.79–2.73 (m, 1H, H16a), 2.66–2.60 (m, 1H, H16b), 2.56–2.49 (m, 1H, H9a), 2.42 (ddd, J = 13.3, 5.3, 2.8 Hz, 1H, H12a), 2.22 (q, J = 7.5 Hz, 2H, H22), 2.18–2.12 (m, 1H, H10a), 2.05 (q, J = 7.2 Hz, 2H, H25), 1.80–1.69 (m, 5H, H3,4,21a), 1.69–1.53 (m, 5H, H9b,10b,17, 21b), 1.43–1.33 (m, 5H, H12b,18,26), 1.29 (app bs, 2H, H19), 0.91 (m, 6H, H20, 27). 13C NMR (125 MHz, CD3OD): δ 166.3 (C), 158.7 (C), 148.6 (C), 147.6 (C), 132.3 (CH), 129.0 (CH), 102.7 (C), 65.0 (CH2), 58.2 (CH), 57.2 (CH), 51.1 (CH), 42.0 (CH2), 34.8 (CH2), 34.0 (CH2), 34.0 (CH2), 32.6 (CH2), 31.7 (CH2), 30.3 (CH2), 29.0 (CH2), 27.5 (CH2), 27.0 (CH2), 26.7 (CH2), 24.0 (CH2), 23.8 (CH2), 23.4 (CH2),14.3 (CH3), 14.1 (CH3). IR (ATR-FTIR), cm−1: 3354 (br), 2958 (w), 2484 (br), 1670 (s). HRMS-CI (m/z): [M]2+ calcd for C27H48N6O2, 244.6931; found, 244.6941.
4.19. Synthesis of the carboxylic acid 24
A round-bottomed flask was charged with the ketone 20c (330 mg, 510 μmol, 1 equiv) and palladium on carbon (10 wt%, 100 mg, 93.9 μmol, 18 mol%). The reaction vessel was sealed with a rubber septum and the headspace was evacuated. The evacuated vessel was back-filled with argon (balloon, 1 atm). This process was repeated three times. The vessel was then cooled in an ice bath to 0 °C. Chilled (−15 °C), freshly-distilled, and degassed trifluoroacetic acid (10 mL) was added. The reaction mixture was stirred for 45 min at 0 °C. The headspace in the reaction vessel was evacuated and then backfilled with dihydrogen (balloon, 1 atm) at 0 °C. The reaction mixture was stirred for 1 h at 0 °C. The reaction mixture was warmed over 20 min to 23 °C. The warmed reaction mixture was stirred for 40 min at 23 °C. The product mixture was cooled to 0 °C. The headspace in the reaction vessel was purged with argon. The product mixture was diluted with methanol (1.0 mL). The diluted product mixture was filtered through a pad of celite (0.8 × 4 cm). The filter cake was washed with methanol (3 × 3.0 mL). The filtrates were combined and the combined filtrates were concentrated. The residue obtained was purified by flash-column chromatography (eluting with 10% methanol–dichloromethane) to provide the carboxylic acid 24 as a white solid (106 mg, 55%). Rf = 0.17 (10% methanol–dichloromethane; UV, PAA). 1H NMR (600 MHz, CD3OD): δ 4.54 (dd, J = 9.6, 6.3 Hz, 1H, H1), 3.81–3.75 (m, 1H, H4), 3.53–3.46 (m, 1H, H13), 2.80–2.75 (m, 1H, H8a), 2.61–2.55 (m, 1H, H8b), 2.52–2.46 (m, 1H, H2a), 2.40 (ddd, J = 13.2, 5.1, 2.7, 1H, H5a), 2.19–2.10 (m, 1H, H3a), 1.75–1.55 (m, 5H, H2b,3b,9,14a), 1.55–1.50 (m, 1H, H14b), 1.49–1.40 (m, 3H, H5b,10), 1.40–1.25 (m, 12H, H11,15–19), 0.97–0.88 (m, 6H, H12,20). 13C NMR (125 MHz, CD3OD): δ 171.5 (C), 163.2 (C), 147.9 (C), 117.3 (C), 58.9 (CH), 57.2 (CH), 51.4 (CH), 35.2 (CH2), 34.3 (CH2), 33.3 (CH2), 32.9 (CH2), 32.7 (CH2), 31.0 (CH2), 30.5 (CH2), 30.3 (CH2), 28.8 (CH2), 27.8 (CH2), 26.3 (CH2), 23.7 (CH2), 23.5 (CH2), 14.4 (CH3), 14.4 (CH2). IR (ATR-FTIR), cm−1: 3335 (br), 2970 (w), 1729 (s), 1699 (m). HRMS-CI (m/z): [M]+ calcd for C22H38N3O2, 376.2959; found, 376.2979.
4.20. Synthesis of the bis(guanidine) 25
N-Methyl-2-chloropyridinium iodide (90.5 mg, 354 μmol, 1.20 equiv) was added to a solution of the carboxylic acid 24 (111 mg, 294 μmol, 1 equiv) in acetonitrile (980 μL) at 23 °C. The reaction mixture was stirred for 1 h at 23 °C. The alcohol 22 (97.8 mg, 295 μmol, 1.00 equiv) and 4-dimethylaminopyridine (27.0 mg, 221 μmol, 0.75 equiv) were then added in sequence. The reaction vessel was placed in an oil bath that had been preheated to 40 °C. The reaction mixture was stirred for 2 h at 40 °C. The mixture was then cooled to 23 °C. The cooled mixture was filtered through a pad of celite (0.8 × 4 cm). The filter cake was washed with ethyl acetate (3 × 5.0 mL). The filtrates were combined and the combined filtrates were concentrated. The residue obtained was transferred to a round-bottomed flask. The reaction vessel was sealed with a rubber septum and the headspace was evacuated. The evacuated vessel was back-filled with argon (balloon, 1 atm). This process was repeated three times. The vessel was then cooled in an ice bath to 0 °C. Chilled (−15 °C), freshly-distilled, and degassed trifluoroacetic acid (5.7 mL) was added to the mixture. The reaction mixture was stirred for 3 h at 0 °C. The cold product mixture was diluted with methanol (2.0 mL). The diluted product mixture was filtered through a pad of celite (0.8 × 4 cm). The filter cake was washed with methanol (3 × 3.0 mL). The filtrates were combined and the combined filtrates were concentrated. The residue obtained was purified by flash-column chromatography (eluting with 5% methanol–dichloromethane) to afford the bis(guanidine) 25 as a colorless oil (64.8 mg, 45% yield over 2 steps). Small amounts of inseparable impurities are observable in the NMR spectra of 25. Rf = 0.10 (5% methanol–dichloromethane; UV, PAA). 1H NMR (600 MHz, CD3OD): δ 4.54 (dd, J = 9.9, 6.1 Hz,1H, H8), 4.23–4.18 (m, 2H, H5), 3.81–3.76 (m, 1H, H11), 3.53–3.48 (m, 1H, H13), 3.22 (t, J = 7.0, 2H, H2), 2.78–2.71 (m, 1H, H16a), 2.66–2.61 (m, 1H, H16b), 2.55–2.47 (m, 1H, H9a), 2.41 (ddd, J = 13.3, 5.4, 2.8, 1H, H12a), 2.16 (dd, J = 12.8, 8.6 Hz,1H, H10a),1.78–1.51 (m,10H, H9b,10b,12b,17,21a,3,4), 1.49–1.25 (m, 15H, H18, 19, 21b,22–26), 0.95–0.85 (m, 6H, H20,27). 13C NMR (125 MHz, CD3OD): δ 166.3 (C), 158.7 (C), 148.5 (C), 147.6 (C), 102.68 (C), 65.0 (CH), 58.2 (CH), 57.2 (CH), 51.5 (CH2), 42.0 (CH2), 34.9 (CH2), 34.0 (2 × CH2), 32.9 (CH2), 32.7 (CH2), 31.7 (CH2), 30.5 (CH2), 30.3 (CH2), 29.0 (CH2), 27.5 (CH2), 27.0 (CH2), 26.7 (CH2), 26.3 (CH2), 23.7 (CH2), 23.4 (CH2), 14.4 (CH3), 14.3 (CH3). IR (ATR-FTIR), cm−1: 3359 (br, w), 2972 (w), 1749 (m), 1716 (m). HRMS-CI (m/z): [M]2+ calcd for C27H50N6O2, 245.7009; found, 245.7001.
4.21. Synthesis of (−)-dehydrobatzelladine C (5)
Ceric ammonium nitrate (72.4 mg, 132 μmol, 1.00 equiv) was added in one portion to a solution of the bis(guanidine) 25 (64.8 mg, 132 μmol, 1 equiv) in acetonitrile (2.6 mL) at 23 °C. The reaction mixture was stirred for 2 h at 23 °C. The product mixture was filtered through a pad of celite (0.8 × 4 cm). The filter cake was washed with methanol (3 × 3.0 mL). The filtrates were combined and the combined filtrates were concentrated. The residue obtained was purified by preparative high-performance liquid chromatography (eluting with 0.1% formic acid–5% acetonitrile–water initially, grading to 0.1% formic acid–49% acetonitrile–water over 15 min, 8 injections) to furnish (−)-dehydrobatzelladine C (5) as a colorless oil (26.0 mg, 40%). Rf = 0.18 (15% methanol–dichloromethane; UV, PAA) 1H NMR (600 MHz, CD3OD): δ 8.46 (bs, 2H, 2 × NH), 4.64–4.54 (m, 1H, H11), 4.37 (t, J = 6.4 Hz, 2H, H5), 3.85–3.76 (m,1H, H13), 3.57 (dd, J = 18.9, 8.5 Hz,1H, H9a), 3.49–3.35 (m, 1H, H9b), 3.23 (t, J = 7.0 Hz, 2H, H2), 3.08 (t, J = 7.7 Hz, 2H, H16), 2.69–2.61 (m, 1H, H10a), 2.57 (dt, J = 13.6, 3.7 Hz, 1H, H12a), 2.09–1.95 (m,1H, H10b),1.90–1.80 (m, 3H, H4,21a), 1.79–1.63 (m, 5H, H3,17,21b), 1.62–1.53 (m, 1H, H12b), 1.51–1.43 (m, 2H, H22), 1.42–1.25 (m, 12H, H18,19,23–26), 0.94–0.86 (m, 6H, H20,27). 13C NMR (125 MHz, CD3OD): δ 181.3 (C), 166.9 (C), 164.7 (C), 158.8 (C), 152.3 (C), 122.7 (C), 66.5 (CH), 63.1 (CH), 53.3 (CH), 42.0 (CH2), 38.5 (CH2), 35.1 (CH2), 34.1 (CH2), 32.9 (CH2), 32.7 (CH2), 31.0 (CH2), 30.6 (CH2), 30.3 (CH2), 30.2 (CH2), 30.1 (CH2), 26.9 (CH2), 26.7 (CH2), 26.0 (CH2), 23.7 (CH2), 23.5 (CH2), 14.4 (CH3), 14.3 (CH3). IR (ATR-FTIR), cm−1: 3350 (br), 2930 (w), 2476 (br), 1672 (s). HRMS-CI (m/z): [M]2+ calcd for C27H48N6O2, 244.6931; found, 244.6941.
Supplementary Material
Acknowledgments
Financial support from the National Institutes of Health (Chemistry Biology Interface Training Program T32GM067543, NRSA fellowship F32GM110898-01A1 to B.T.P), the National Science Foundation (GRFP DGE-1752134 to J.P.R.), and Yale University are gratefully acknowledged.
Footnotes
Appendix A. Supplementary data
Supplementary data related to this article can be found at https://doi.org/10.1016/j.tet.2018.04.050.
References
- 1.Patil AD, Kumar NV, Kokke WC, et al. J Org Chem. 1995;60:1182–1188. [Google Scholar]
- 2.Patil AD, Freyer AJ, Taylor PB, et al. J Org Chem. 1997;62:1814–1819. [Google Scholar]
- 3.Braekman JC, Daloze D, Tavares R, Hajdu E, Van Soest RWM. J Nat Prod. 2000;63:193–196. [DOI] [PubMed] [Google Scholar]
- 4.Hua HM, Peng J, Dunbar DC, et al. Tetrahedron. 2007;63:11179–11188. [Google Scholar]
- 5.Laville R, Thomas OP, Berrué F, Marquez D, Vacelet J, Amade P. J Nat Prod. 2009;72:1589–1594. [DOI] [PubMed] [Google Scholar]
- 6.Rao AVR, Gurjar MK, Vasudevan J. J Chem Soc, Chem Commun. 1995:1369–1370. [Google Scholar]
- 7.Snider BB, Chen J, Patil AD, Freyer AJ. Tet Lett. 1996;37:6977–6980. [Google Scholar]
- 8.Snider BB, Chen J. Tet Lett. 1998;39:5697–5700. [Google Scholar]
- 9.Cohen F, Overman LE, Sakata SK. Org Lett. 1999;1:2169–2172. [DOI] [PubMed] [Google Scholar]
- 10.Franklin AS, Ly SK, Mackin GH, Overman LE, Shaka AJ. J Org Chem. 1999;64: 1512–1519. [DOI] [PubMed] [Google Scholar]
- 11.Overman LE, Wolfe JP. J Org Chem. 2001;66:3167–3175. [DOI] [PubMed] [Google Scholar]
- 12.Cohen F, Overman LE. J Am Chem Soc. 2001;123:10782–10783. [DOI] [PubMed] [Google Scholar]
- 13.Duron SG, Gin DY. Org Lett. 2001;3:1551–1554. [DOI] [PubMed] [Google Scholar]
- 14.Ishiwata T, Hino T, Koshino H, Hashitnoto Y, Nakata T, Nagasawa K. Org Lett. 2002;4:2921–2924. [DOI] [PubMed] [Google Scholar]
- 15.Collins SK, McDonald AI, Overman LE, Rhee YH. Org Lett. 2004;6:1253–1255. [DOI] [PubMed] [Google Scholar]
- 16.Bewley CA, Ray S, Cohen F, Collins SK, Overman LE. J Nat Prod. 2004;67: 1319–1324. [DOI] [PubMed] [Google Scholar]
- 17.Elliott MC, Long MS. Org Biomol Chem. 2004;2:2003–2011. [DOI] [PubMed] [Google Scholar]
- 18.Shimokawa J, Shirai K, Tanatani A, Hashimoto Y, Nagasawa K. Angew Chem Int Ed. 2004;43:1559–1562. [DOI] [PubMed] [Google Scholar]
- 19.Shimokawa J, Ishiwata T, Shirai K, et al. Chem Eur J. 2005;11:6878–6888. [DOI] [PubMed] [Google Scholar]
- 20.Arnold MA, Duro SG, Gin DY. J Am Chem Soc. 2005;127:6924–6925. [DOI] [PubMed] [Google Scholar]
- 21.Cohen F, Overman LE. J Am Chem Soc. 2006;128:2594–2603. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Cohen F, Overman LE. J Am Chem Soc. 2006;128:2604–2608. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Arnold MA, Day KA, Duron SG, Gin DY. J Am Chem Soc. 2006;128:13255–13260. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Aron ZD, Overman LE. Chem Commun. 2004:253–265. [DOI] [PubMed] [Google Scholar]
- 25.Berlinck RGS, Kossuga MH. Nat Prod Rep. 2005;22:516–550. [DOI] [PubMed] [Google Scholar]
- 26.Morris JC, Nicholas M, Phillips AJ. Nat Prod Rep. 2007;24:87–108. [DOI] [PubMed] [Google Scholar]
- 27.Parr BT, Economou C, Herzon SB. Nature. 2015;525:507–510. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Gonzalez DF, Brand JP, Waser J. Chem Eur J. 2010;16:9457–9461. [DOI] [PubMed] [Google Scholar]
- 29.Reddy RP, Davies HML. J Am Chem Soc. 2007;129:10312–10313. [DOI] [PubMed] [Google Scholar]
- 30.Moloney MG, Pinhey JT, Roche EG. Tet Lett. 1986;27:5025–5028. [Google Scholar]
- 31.Moloney MG, Pinhey JT, Roche EG. J Chem Soc Perkin Trans. 1989;1:333–341. [Google Scholar]
- 32.Krasovskiy A, Kopp F, Knochel P. Angew Chem Int Ed. 2006;45:497–500. [DOI] [PubMed] [Google Scholar]
- 33.Sano S, Shimizu H, Nagao Y. Tet Lett. 2005;46:2883–2886. [Google Scholar]
- 34.Mukaiyama T Angew Chem Int Ed. 1979;18:707–721. [Google Scholar]
- 35.Still WC, Kahn M, Mitra A. J Org Chem. 1978;43:2923–2925. [Google Scholar]
- 36.Pangborn AB, Giardello MA, Grubbs RH, Rosen RK, Timmers FJ. Organometallics. 1996;15:1518–1520. [Google Scholar]
- 37.Love BE, Jones EG. J Org Chem. 1999;64:3755–3756. [DOI] [PubMed] [Google Scholar]
- 38.Jat JL, De SR, Kumar G, Adebesin AM, Gandham SK, Falck JR. Org Lett. 2015;17: 1058–1061. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Zhu C, Xu G, Sun J. Angew Chem Int Ed. 2016;55:11867–11871. [DOI] [PubMed] [Google Scholar]
- 40.Botta M, Corelli F, Maga G, Manetti F, Spadari S. Tetrahedron. 2001;57: 8357–8367. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
